Roots Analysis

FEBRUARY 22, 2022

Autoinjector As Emerging Drug Delivery Device. One of the most widely recognized autoinjector in the market is EpiPen® (Mylan), which is a prefilled epinephrine autoinjector. The market landscape is predominantly characterized by the presence of several small and mid-sized companies with a few established players.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

pharmaphorum

OCTOBER 12, 2022

Sustainability for Injectable Delivery Devices. Connected Drug Delivery Devices. Benefits of Attending: Engage with industry representatives on the latest trends within the pre-filled syringe and injectable device market. Hear about new technological advances in the delivery of large volume drugs.

Drugs 52

Drugs Packaging Packaging Drug Delivery 52

The Pharma Data

OCTOBER 27, 2020

European market launch of both COVID-19 tests planned for Q1 2021. 3a will continue to advance its industrial design, product usability, labelling compliance, regulatory approval, and production planning work in parallel to its validation studies. 25-minute RT-PCR lab test to complement 15-minute rapid test.

RNA 52

RNA Drug Delivery Production In-Vitro 52

Delveinsight

NOVEMBER 26, 2020

However, for such a burdensome and highly prevalent sight-threatening eye disorder, the Retinal vein occlusion treatment market has no curative option to offer. Retinal vein occlusion drug market. The present market lacks an effective treatment to unblock retinal veins.

Marketing 63

Marketing FDA Approval Drugs Drug Delivery Systems 63

XTalks

AUGUST 30, 2022

Strategic leaders know how to think critically and navigate through daily challenges that are bound to emerge in this competitive market. The pharmaceutical industry deals with threats such as product liability, cyberthreats, supply chain disruptions, competition from generic drugs and more. Transformational Leadership.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105

XTalks

JUNE 11, 2024

Drug-eluting stents (DES): DES reduce the incidence of restenosis and are coated with drugs that inhibit scar tissue growth. DCBs: DCBs, such as the Agent DCB, combine mechanical widening of the artery with drug delivery to the vessel wall to prevent cell proliferation.

Drugs 52

Drugs Drug Delivery Cardiology Marketing 52

Roots Analysis

MAY 24, 2024

In the dynamic landscape of the healthcare sector, the evolution of drug delivery systems plays a significant role in transforming the management of chronic diseases. These devices reduce injection anxiety, and are useful for patients who prefer a hands-free drug delivery experience.

Drug Delivery 40

Drug Delivery Containment Contamination Production 40

The Pharma Data

DECEMBER 28, 2020

Stetsenko has helped acquire, build and exit businesses via public markets and raising capital for companies in the technology, healthcare, communications and natural resources sectors. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization.

Containment 52

Containment Drug Delivery Compliance Marketing 52

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. Post-market, combination products potentially face the same enforcement scrutiny as single-entity medical devices. By John W.M.

Regulation 59

Regulation Production Drug Delivery Marketing 59

The Pharma Data

DECEMBER 20, 2020

It is our continual objective to broaden our product scope, and Transcend, with its experienced management team, is a perfect foothold for us in the fast-growing market for psychedelics molecules and complements our existing pipeline of treatments. “We are very pleased to close our acquisition of Transcend. About BetterLife Pharma Inc.

Drug Delivery 52

Drug Delivery Containment Production Development 52

XTalks

FEBRUARY 24, 2021

For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Traditional needles on the market range between 8 and 12.5 Related: Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market.

Insulin 64

Insulin Production Drug Delivery Marketing 64

Roots Analysis

JANUARY 17, 2024

They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. Prefilled syringes are syringes that come pre-filled with a specific dose of medication.

Drug Delivery 40

Drug Delivery Contamination Drugs Production 40

XTalks

JULY 5, 2022

A corporate compliance training program is a part of many onboarding programs to ensure employees are up to date with the latest rules and regulations they must adhere to while working for the company. Novartis trains and guides associates with a structured program consisting of ethics, risk and compliance.

Life Science 52

Life Science Compliance Packaging Packaging 52

The Pharma Data

DECEMBER 17, 2020

“We are pleased with the expeditious review and approval of our market authorization application for Buvidal by Swissmedic and that patients with opioid dependence in Switzerland will now have access to an effective long-acting treatment,” says Fredrik Tiberg , PhD, President & CEO of Camurus. LUND, Sweden , Dec.

Clinical Trials 52

Clinical Trials Clinical Trials Drug Delivery Production 52

The Pharma Data

OCTOBER 14, 2020

15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312.

Drugs 40

Drugs Allergies Cardiology Medicine 40

The Pharma Data

NOVEMBER 4, 2020

His broad leadership experience in the pharmaceutical industry, from intellectual property and regulatory compliance to product manufacturing and distribution, presents an exciting opportunity for XPhyto,” said Hugh Rogers, CEO of XPhyto. Thoresen is an important addition to XPhyto’s board of directors.

Drug Delivery 40

Drug Delivery Production Manufacturing Development 40

Roots Analysis

SEPTEMBER 13, 2023

Conjugation with a Variety of Molecular Conjugates and Labels The combination of the conjugates / labels with molecules ( proteins, peptides, antibodies and small molecules ) is being used abundantly for several applications, ranging from therapeutics and diagnostics to isolation and characterization of drug delivery systems.

Development 40

Development Antibody Protein Drug Delivery Systems 40

The Pharma Data

JANUARY 3, 2021

“We are delighted to support our partnership with EyePoint through this investment, as we prepare for the development and commercialization of YUTIQ and DEXYCU, under Ocumension branded labels, across Asian markets,” said Ye Liu, Chief Executive Officer of Ocumension. “We

Production 52

Production Sales Development Licensing 52

The Pharma Data

JANUARY 27, 2021

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.

In-Vitro 52

In-Vitro Containment Drugs Production 52

The Pharma Data

DECEMBER 14, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. About BetterLife Pharma Inc. BetterLife Pharma Inc. For further information please visit www.abetterlifephama.com. About Transcend Biodynamics.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

XTalks

NOVEMBER 6, 2024

per share, the offering included 1,300,000 ordinary shares, which began trading on the Nasdaq Global Market under the ticker symbol GELS on October 29, 2024. With an expanding patent portfolio and partnerships in human and animal health, Gelteq promotes therapeutic efficacy and patient adherence across diverse health markets.

Drug Delivery 104

Drug Delivery Drugs Bioequivalency Bioavailability 104

Delveinsight

JANUARY 22, 2021

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market.

Marketing 65

Marketing Drugs Antibody Compliance 65

Roots Analysis

SEPTEMBER 22, 2023

These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery. These significant benefits offered by wearable injectors, coupled with their rising demand in the pharmaceutical industry and healthcare sector, worldwide is likely to drive market growth during in the coming years.

Drug Delivery 40

Drug Delivery Marketing Insulin Drugs 40

XTalks

MAY 23, 2024

There is an unmet medical need to bring to the market a non-invasive, cost effective and aesthetically acceptable treatment, which is also relatively painless and easily accessible in an outpatient setting. TDDS are advantageous due to their high bioavailability, low systemic toxicity and improved patient compliance.

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

pharmaphorum

NOVEMBER 17, 2021

SMi presents the Inaugural: Transdermal and Microneedle Drug Delivery Conference. Latest innovations in drug delivery beyond the needle. SMi is proud to present the Transdermal and Microneedle Drug Delivery Conference, taking place on the 24th to 25th January 2022, in London. pharmaphorum .

Drug Delivery 52

Drug Delivery Drugs Vaccination Vaccine 52

pharmaphorum

JUNE 22, 2021

This morning the drugmaker’s majority owned HIV unit ViiV Healthcare announced a partnership with drug delivery specialist Halozyme to develop four HIV therapies that could be dosed as infrequently as once every six months or more.

Antibody 52

Antibody Protein Drug Delivery Drugs 52

Roots Analysis

MARCH 9, 2022

Biopharmaceutical Excipient Manufacturing Market. Given the evident benefits of biologics over small molecule drugs (including high efficacy, target specificity and favorable safety profiles), the biopharmaceutical market is poised to witness continued and consistent growth over the next several years. Capacity Analysis.

Manufacturing 52

Manufacturing Marketing Contract Manufacturing Protein 52

The Pharma Data

JANUARY 16, 2021

Its proprietary large-capacity flow electroporator, X-Porator F1, is one of the only two products of its kind in the world, and leads the market with its outstanding performance and customer value. Etta Biotech is a leading cell electroporation technology and equipment supplier. JS Bio’s parent company. About JS Bio.

Protein 52

Protein Production Antibody In-Vitro 52

pharmaphorum

JUNE 10, 2021

Quite often, middlemen like PBMs can earn as much revenue as a manufacturer on a given drug, and with just three major PBMs serving a majority of the market, their power is quite concentrated. He is an experienced executive, business analyst and consultant in the realm of pharmaceutical regulatory compliance and government pricing.

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

Roots Analysis

JANUARY 27, 2025

In order to help circumvent these disadvantages, several drug delivery devices, which enable patients to self-administer drugs through subcutaneous route are now being developed. Further, the majority of the companies in the approved market are presently headquartered in North America.

Marketing 40

Marketing Drug Delivery Development Protein 40